Clarivate reported Q4 2025 revenue of $617 million, a decline of 6.9% compared to the prior year, primarily due to divestitures. However, the company returned to profitability with a net income of $3.1 million and announced a strategic pivot to sell its Life Sciences & Healthcare business to focus on Intellectual Property and Academia segments.

Clarivate delivered a strong third quarter in 2025, exceeding expectations with a 7% increase in total revenue to $720 million. The company's focus on subscription and re-occurring revenue proved successful, contributing significantly to the growth. Adjusted EBITDA also saw a healthy rise, indicating improved operational efficiency. The company's strategic initiatives and market position continue to drive positive financial outcomes.

Clarivate reported total revenues of $593.7 million for the first quarter of 2025, a decrease from $621.2 million in the prior year. The company experienced a net loss of $103.9 million, or $0.15 per diluted share, and generated $171.2 million in operating cash flow. Despite the revenue decline, organic recurring revenues increased by 0.6%, driven by higher IP patent renewal volumes.

Clarivate's Q4 2024 revenue decreased by 3.0% year-over-year to $663.0 million, mainly due to divestitures. The company posted a net loss of $191.8 million, a significant improvement from the previous year's loss. Adjusted EPS came in at $0.21, down from $0.23. The company repurchased $200 million in shares and prepaid $198 million of debt as part of its capital allocation strategy.

Clarivate's Q3 2024 revenues decreased by 3.9% to $622.2 million, with a net loss of $65.6 million. The company's performance was impacted by lower transactional sales and the divestiture of Valipat. As a result of the recent CEO transition and the work being done under the Value Creation Plan, the Company has removed its forward-looking outlook for 2024.

Clarivate reported a 2.8% decrease in revenues to $650.3 million, with organic revenues down 0.6%. Subscription revenues increased, but were offset by declines in re-occurring and transactional revenues. The company reaffirmed its 2024 outlook, expecting a return to organic growth in the second half of the year.

Clarivate's first quarter results showed a slight decrease in revenues, driven by declines in transactional and re-occurring revenues, which offset growth in subscription revenues. The company reported a net loss attributable to ordinary shares and a decrease in adjusted EBITDA. However, Clarivate reaffirmed its full-year 2024 outlook.

Clarivate's Q4 2023 saw a revenue increase of 1.2% to $683.7 million, but experienced a net loss of $863.0 million due to non-cash impairment charges. Subscription and re-occurring revenues grew, offsetting a decline in transactional revenue. The company is implementing a transformation plan to improve organic revenue growth.

Clarivate reported a revenue increase of 1.8% to $647.2 million in Q3 2023. Organic revenues increased by 1.7%, driven by transactional and subscription revenue growth. The company reaffirmed its 2023 outlook, highlighting cost savings and strategic capital allocation.

Clarivate reported a decrease in revenues by 2.6% to $668.8 million, driven by the divestiture of MarkMonitor. Organic revenues decreased slightly by 0.4%. Net loss attributable to ordinary shares was $141.7 million. Adjusted EBITDA increased by 3.8% to $284.9 million, with an Adjusted EBITDA Margin of 42.6%.

Clarivate reported a 5.0% decrease in revenues to $629.1 million, driven by the divestiture of MarkMonitor and currency headwinds. Despite this, the company saw a 3.1% increase in subscription revenues and a significant rise in free cash flow to $168.2 million. The company reaffirmed its 2023 outlook, anticipating an acceleration of organic growth.

Clarivate reported a 20.4% increase in revenues to $675.3 million, driven by the acquisition of ProQuest. Organic revenues increased by 0.5%. Net income attributable to ordinary shares was $304.3 million, a significant increase compared to the prior year quarter's net loss. Adjusted EBITDA increased by 18.6% to $304.4 million.

Clarivate's Q3 2022 revenues increased by 43.8% to $635.7 million, driven by the acquisition of ProQuest. Organic revenues grew by 1.2%, with subscription and re-occurring revenue increases offset by a decline in transactional revenues. The company reported a net loss of $4,434.4 million due to a $4,448.6 million non-cash impairment of goodwill.

Clarivate reported a 54.0% increase in revenues to $686.6 million, with organic revenues increasing by 4.8%. Net income attributable to ordinary shares increased by $175.2 million to $43.7 million. Adjusted EBITDA increased by 45.2% to $274.4 million.

Clarivate reported revenues of $662.2 million, a 54.6% increase, with organic revenues increasing 4.4% at constant currency. Net income attributable to ordinary shares was $50.8 million, and Adjusted EBITDA was $262.3 million, a 59.2% increase.

Clarivate reported a 23.1% increase in revenues to $560.7 million for Q4 2021. Adjusted EBITDA increased by 28.3% to $256.6 million. The company reaffirms its outlook for 2022 and is taking steps to improve transactional revenues.

Clarivate reported a 55% increase in revenues to $442.1 million and a 76% increase in Adjusted EBITDA to $190.0 million. Net income improved to $0.9 million, and Adjusted EPS rose to $0.16. The company reaffirms its outlook for 2021 and extended its share repurchase program.

Clarivate reported a strong second quarter with a 62.9% increase in revenue to $445.6 million. Organic revenue grew by 4.5% on a constant currency basis, driven by higher subscription and transactional revenues. Adjusted EBITDA increased by 88.8% to $189.0 million, and adjusted net income rose by 58.3% to $110.0 million.

Clarivate reported a strong first quarter in 2021, with revenues of $428.4 million, a 78% increase year-over-year. Adjusted EBITDA increased by 111% to $164.8 million, and the company updated its 2021 financial outlook.

Clarivate reported a strong fourth quarter and full-year 2020, driven by strategic acquisitions and operational improvements. Fourth-quarter revenues increased by 79% to $456 million, with net income rising by 108% to $6 million. The company reaffirmed its 2021 outlook, citing the strength of its core business and expected benefits from recent acquisitions.

Clarivate reported a 17.0% increase in revenues to $284.4 million for Q3 2020. Adjusted EBITDA increased by 40.5% to $108.2 million. The company completed the acquisition of CPA Global and is focused on integration and realizing strategic benefits.

Clarivate reported a 12.9% increase in revenues to $273.5 million and a 36.7% increase in Adjusted EBITDA to $100.1 million. The company reaffirmed its outlook for 2020, anticipating adjusted revenues between $1.13B and $1.16B and adjusted EBITDA between $395M and $420M.

Clarivate reported a revenue increase of 2.8% to $240.6 million in Q1 2020. Adjusted EBITDA increased by 32.1% to $78.2 million. The company also updated its outlook for 2020, reflecting the impact of the COVID-19 pandemic.